Reuters logo
4 个月前
BRIEF-Bausch + Lomb Canada launches bepreve 1.5 pct w/v for allergic conjunctivitis
2017年3月22日 / 中午11点47分 / 4 个月前

BRIEF-Bausch + Lomb Canada launches bepreve 1.5 pct w/v for allergic conjunctivitis

1 分钟阅读

March 22 (Reuters) - Valeant Pharmaceuticals International Inc:

* Bausch + Lomb - Bausch + Lomb Canada launches bepreve (bepotastine besilate ophthalmic solution) 1.5 pct w/v for allergic conjunctivitis Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below